Security key
000899104
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 8,911,060
- Total 13F value
- $33,198,000
- Share change
- -317,017
- SEC-reported price per share
- $3.70
- Number of holders
- 19
- Value change
- -$1,175,766
- Number of buys
- 5
- Number of sells
- 7
- Shares outstanding
- 238,388,839
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2017
Institutions
19
Top holders
10
ADMA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2017
Previous quarter: Q1 2017
ADMA BIOLOGICS, INC. SEC filings
ADMA BIOLOGICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 000899104
Recent filing periods:
Ownership snapshot
Top reported holders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Aisling Capital LLC
Disclosed value leader
Aisling Capital LLC
Comparable rows
15/15
Latest evidence
31 Mar 2017
13F
Lead comparable stake: 1.5%
Showing 1-6 of 15 holder rows.
Quick read
Aisling Capital LLC leads the comparable SEC ownership view at 1.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Aisling Capital LLC's linked filing trail.
Comparable ownership
Top 5
Aisling Capital LLC
1.5%
Biomark Capital Management Co. LLC
0.6%
Consonance Capital Management LP
0.53%
Broadfin Capital, LLC
0.43%
PERCEPTIVE ADVISORS LLC
0.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Aisling Capital LLC |
13F
Company
|
1.5%
|
$17,608,000
3,608,171 shares
|
— | 31 Mar 2017 |
| Biomark Capital Management Co. LLC |
13F
Company
|
0.6%
|
$6,995,000
1,433,304 shares
|
— | 31 Mar 2017 |
| Consonance Capital Management LP |
13F
Company
|
0.53%
|
$6,217,000
1,273,933 shares
|
— | 31 Mar 2017 |
| Broadfin Capital, LLC |
13F
Company
|
0.43%
|
$5,020,000
1,028,672 shares
|
— | 31 Mar 2017 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
0.3%
|
$3,519,000
721,102 shares
|
— | 31 Mar 2017 |
| FMR LLC |
13F
Company
|
0.17%
|
$1,951,000
399,700 shares
|
— | 31 Mar 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
8,911,060
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
17
Q2 2017 holders
19
Holder diff
2
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 value | Q2 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend